Cargando…
Striatal Astrocytes Act as a Reservoir for L-DOPA
L-DOPA is therapeutically efficacious in patients with Parkinson’s disease (PD), although dopamine (DA) neurons are severely degenerated. Since cortical astrocytes express neutral amino acid transporter (LAT) and DA transporter (DAT), the uptake and metabolism of L-DOPA and DA in striatal astrocytes...
Autores principales: | Asanuma, Masato, Miyazaki, Ikuko, Murakami, Shinki, Diaz-Corrales, Francisco J., Ogawa, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154692/ https://www.ncbi.nlm.nih.gov/pubmed/25188235 http://dx.doi.org/10.1371/journal.pone.0106362 |
Ejemplares similares
-
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
por: Asanuma, Masato, et al.
Publicado: (2016) -
l-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes
por: Takeshima, Mika, et al.
Publicado: (2016) -
Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine
por: Asanuma, Masato, et al.
Publicado: (2019) -
Lack of Dopaminergic Inputs Elongates the Primary Cilia of Striatal Neurons
por: Miyoshi, Ko, et al.
Publicado: (2014) -
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)